The gut microbiota and psychiatric illness

Journal of Psychiatry and Neuroscience

Volumn 42, Issue 2, 2017, Pages 75-77

  MacQueen, Glenda ^a   Surette, Michael ^b   Moayyedi, Paul ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

ANXIETY; AUTISM; BECK DEPRESSION INVENTORY; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; CHRONIC FATIGUE SYNDROME; DIGESTIVE SYSTEM FUNCTION DISORDER; EDITORIAL; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL STRESS; NONHUMAN; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); ANIMAL; MICROBIOLOGY;

ANIMALS; GASTROINTESTINAL MICROBIOME; HUMANS; MENTAL DISORDERS;

EID: 85013942128     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.170028     Document Type: Editorial

References (30)

1. Probiotic market by application (food and beverages, dietary supplements, animal feed) by end users (human probiotics, animal probiotics)-global industry analysis, size, share, growth and forecast 2014–2020. Albany (NY): Transparency Market Research; 2015. Available: www.transparencymarketresearch.com/probiotics-market.html (accessed 2017 Jan. 6).
2. Dinan TG, Cryan JF. Gut-brain axis in 2016: brain-gut-microbiota axis — mood, metabolism and behaviour. Nat Rev Gastroenterol Hepatol 2017;14:69-70.
3. Foster JA. Gut microbiome and behavior: focus on neuroimmune interactions. Int Rev Neurobiol 2016;131:49-65.
4. Anglin R, Surette M, Moayyedi P, et al. Lost in translation: the gut microbiota in psychiatric illness. Can J Psychiatry 2015;60:460-3.
5. Bercik P, Denou E, Collins J, et al. The intestinal microbiota affect central levels of brain-derived neurotrophic factor and behavior in mice. Gastroenterology 2011;141:599-609.
6. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 2011;108: 16050-5.
7. Bercik P, Park AJ, Sinclair D, et al. The anxiolytic effect of Bifido-bacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011;23:1132-9.
8. Lyte M, Li W, Opitz N, et al. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav 2006; 89:350-7.
9. Goehler LE, Gaykema RP, Opitz N, et al. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun 2005;19:334-44.
10. Bharwani A, Mian MF, Foster JA, et al. Structural & functional consequences of chronic psychosocial stress on the microbiome & host. Psychoneuroendocrinology 2016;63:217-27.
11. Bailey MT, Dowd SE, Galley JD, et al. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun 2011;25:397-407.
12. Li W, Dowd SE, Scurlock B, et al. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav 2009;96:557-67.
13. Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014;109:1547-61.
14. Steenbergen L, Sellaro R, van Hemert S, et al. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun 2015;48:258-64.
15. Schmidt K, Cowen PJ, Harmer CJ, et al. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl) 2015;232:1793-801.
16. Tillisch K, Labus J, Kilpatrick L, et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013;144:1394-401.
17. Jiang H, Ling Z, Zhang Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 2015;48:186-94.
18. Zheng P, Zeng B, Zhou C, et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry 2016;21:786-96.
19. Naseribafrouei A, Hestad K, Avershina E, et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil 2014;26:1155-62.
20. Kelly JR, Borre Y, O’Brien C, et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res 2016;82:109-18.
21. Aizawa E, Tsuji H, Asahara T, et al. Possible association of Bifido-bacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. J Affect Disord 2016;202:254-7.
22. Tomasik J, Yolken RH, Bahn S, et al. Immunomodulatory effects of probiotic supplementation in schizophrenia patients: a randomized, placebo-controlled trial. Biomark Insights 2015;10:47-54.
23. Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition 2016;32:315-20.
24. Dinan TG, Cryan JF. Mood by microbe: towards clinical translation. Genome Med 2016;8:36.
25. Marshall JK, Thabane M, Garg AX, et al. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010;59:605-11.
26. Jones R, Latinovic R, Charlton J, et al. Physical and psychological comorbidity in irritable bowel syndrome: a matched cohort study using the General Practice Research Database. Aliment Pharmacol Ther 2006;24:879-86.
27. Ananthakrishnan AN, Gainer VS, Cai T, et al. Similar risk of depression and anxiety following surgery or hospitalization for Crohn’s disease and ulcerative colitis. Am J Gastroenterol 2013;108:594-601.
28. Ford AC, Bercik P, Morgan DG, et al. Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria. Aliment Pharmacol Ther 2014;39:312-21.
29. Roy-Byrne PP, Davidson KW, Kessler RC, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psych 2008;30:208-25.
30. Liu Y, Zhang L, Wang X, et al. Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression. Clin Gastroenterol Hepatol 2016;14:1602-61.